222 related articles for article (PubMed ID: 8895700)
1. Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea.
Pulik M; Lionnet F; Genet P; Petitdidier C; Jary L; Touahri T
Am J Hematol; 1996 Nov; 53(3):207-8. PubMed ID: 8895700
[No Abstract] [Full Text] [Related]
2. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
Cacciola E; Cacciola RR; Guglielmo P; Stagno F; Giustolisi R
Haematologica; 1999 Aug; 84(8):755-6. PubMed ID: 10457418
[No Abstract] [Full Text] [Related]
4. Spurious glycohemoglobin values associated with hydroxyurea treatment.
Karsegard J; Wicky J; Mensi N; Caulfield A; Philippe J
Diabetes Care; 1997 Jul; 20(7):1211-2. PubMed ID: 9203471
[No Abstract] [Full Text] [Related]
5. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
Tóthová E; Nebesnáková E; Kafková A; Stecová N; Fricová M
Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea-induced leg ulcers treated with a protease-modulating matrix.
Romanelli M; Dini V; Romanelli P
Arch Dermatol; 2007 Oct; 143(10):1310-3. PubMed ID: 17938346
[TBL] [Abstract][Full Text] [Related]
7. [Polycythemia vera terminating in myelodysplastic syndrome].
Kimura S; Uoshima N; Tanaka R; Kobayashi Y; Ozawa M; Maruo N; Kondo M; Abe T; Yoshida Y
Rinsho Ketsueki; 1990 Jan; 31(1):100-4. PubMed ID: 2313900
[TBL] [Abstract][Full Text] [Related]
8. Oral squamous cell carcinoma during long-term treatment with hydroxyurea.
De Benedittis M; Petruzzi M; Giardina C; Lo Muzio L; Favia G; Serpico R
Clin Exp Dermatol; 2004 Nov; 29(6):605-7. PubMed ID: 15550132
[TBL] [Abstract][Full Text] [Related]
9. Is hydroxyurea leukemogenic in essential thrombocythemia?
Tefferi A
Blood; 1998 Aug; 92(4):1459-60; author reply 1460-1. PubMed ID: 9694740
[No Abstract] [Full Text] [Related]
10. Improvement of fibrosis in a patient with chronic myeloproliferative disease.
Retter A; Radia DH; Harrison CN
Br J Haematol; 2007 Nov; 139(3):350. PubMed ID: 17910624
[No Abstract] [Full Text] [Related]
11. The optimal management of polycythaemia vera.
McMullin MF; Bareford D; Craig J; Green AR; Harrison C; Oscier DG; Reilly JT;
Br J Haematol; 2003 Feb; 120(3):543-4; author reply 544-5. PubMed ID: 12580978
[No Abstract] [Full Text] [Related]
12. Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.
Ellis AK; Lee DH
Am J Hematol; 2002 Nov; 71(3):237-8. PubMed ID: 12410589
[No Abstract] [Full Text] [Related]
13. Management of polycythemia vera with hydroxyurea.
Tatarsky I; Sharon R
Semin Hematol; 1997 Jan; 34(1):24-8. PubMed ID: 9025159
[No Abstract] [Full Text] [Related]
14. Long-term management of polycythemia vera with hydroxyurea: a progress report.
Kaplan ME; Mack K; Goldberg JD; Donovan PB; Berk PD; Wasserman LR
Semin Hematol; 1986 Jul; 23(3):167-71. PubMed ID: 3749925
[No Abstract] [Full Text] [Related]
15. Acute leukemia in polycythemia vera.
Landaw SA
Semin Hematol; 1986 Apr; 23(2):156-65. PubMed ID: 3704667
[No Abstract] [Full Text] [Related]
16. [Leg ulcer in a patient treated with hydroxyurea for polycythemia vera].
Hanchi I; Zeglaoui F; Ezzine N; Daoud L; Karoui M; Fazaa B; Ridha Kamoun M
Presse Med; 2006; 35(7-8):1174-6. PubMed ID: 16840894
[TBL] [Abstract][Full Text] [Related]
17. Unusually prolonged survival of a case of acute megakaryoblastic leukemia secondary to long-standing polycythemia vera.
Stamatopoulos K; Yataganas X; Papadaki T; Paterakis G
Leuk Res; 2002 Jul; 26(7):699-700. PubMed ID: 12008090
[No Abstract] [Full Text] [Related]
18. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
Nielsen I; Hasselbalch HC
Am J Hematol; 2003 Sep; 74(1):26-31. PubMed ID: 12949887
[TBL] [Abstract][Full Text] [Related]
19. Multiple myeloma and acute myelomonocytic leukemia.
Kyle RA; Pierre RV; Bayrd ED
N Engl J Med; 1970 Nov; 283(21):1121-5. PubMed ID: 5273282
[No Abstract] [Full Text] [Related]
20. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
Vélez A; García-Aranda JM; Moreno JC
J Eur Acad Dermatol Venereol; 1999 May; 12(3):243-4. PubMed ID: 10461646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
